CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title | Date of Registration | State |
---|---|---|
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors. | 2010-12-17 | Registered |
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I | 03/11/2017 | Registered |
Vaxira as adjuvant treatment for non-small cell lung cancer | 15/12/2015 | Registered outdated |
VSSP in metastasic renal cell carcinoma | 08/08/2018 | Registered |
VSSP in renal cell carcinoma | 08/04/2021 | Registered |
VSSPs in renal carcinoma. | 21/06/2023 | Registered |